Company Filing History:
Years Active: 2014-2016
Title: Innovations of Justin N Huard
Introduction
Justin N Huard is an accomplished inventor based in Seattle, WA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in cancer treatment. With a total of 2 patents, his work is paving the way for innovative therapies.
Latest Patents
Among his latest patents, Justin has developed fused tricyclic dual inhibitors of CDK 4/6 and FLT3. These compounds, referred to as Compounds of Formula I, are useful inhibitors of CDK 4, CDK 6, and FLT3. Such compounds are instrumental in treating cancer and various other disease conditions. The structure of these compounds is defined in detail within the patent documentation.
Career Highlights
Justin is currently employed at Amgen Inc., a leading biotechnology company. His role involves extensive research and development aimed at creating effective treatments for serious health conditions. His innovative approach and dedication to his work have earned him recognition in the scientific community.
Collaborations
Justin collaborates with talented colleagues, including Xiaoqi Chen and Kang Dai. Together, they work on advancing research that has the potential to transform cancer therapies.
Conclusion
Justin N Huard's contributions to the field of pharmaceuticals highlight the importance of innovation in developing new treatments for cancer. His work exemplifies the impact that dedicated inventors can have on healthcare advancements.